Ebola outbreak in DR Congo surges to second-largest on record
By Nana Karikari, Senior Global Affairs Correspondent
The fast-growing Ebola outbreak in the Democratic Republic of Congo has grown into the second-largest on record, with cases taking just weeks to hit levels that took years in previous epidemics. World Health Organization data published Friday reveals at least 3,553 confirmed cases and 1,558 deaths since the outbreak was identified in mid-May. In just over two months, the current figures have surpassed the total recorded during the historic 2018-2020 epidemic in the country.
Carl Skau, acting head of the United Nations World Food Programme, described the severity of the situation to the Reuters news agency. “It’s the fastest spreading Ebola epidemic that we have ever seen,” Skau said. “The world needs to pay much more attention.”
The epidemic is currently second only to the 2014-2016 West Africa outbreak that resulted in more than 28,600 cases and 11,325 deaths. Health agencies note that the true scale of the current crisis could be significantly higher than official counts indicate.
Complex Realities on the Ground Hinder Containment Efforts
Medical personnel are battling the rare Bundibugyo strain of the virus, for which standard vaccines and treatments were not initially available. Active conflict, the presence of numerous armed groups, high population mobility around lucrative gold mines, and a dense concentration of displaced individuals in Ituri province have severely complicated response measures.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus addressed the escalating trajectory this month. “Despite the progress we have made, the outbreak in DRC is continuing to outpace the response,” Dr. Tedros said. “Intense transmission in the province of Ituri remains our biggest concern.”
Local residents face profound psychological and physical tolls amid persistent instability. Deborah Nzuva, a mother of four living in Rwampara, shared her perspective on the ground. “I fear that at some point, life may come to a standstill here in our province of Ituri,” Nzuva said. “We were already in a precarious situation before the Ebola virus disease, which continues to claim its victims.”
Community transmission remains high because approximately two-thirds of fatalities occur outside health facilities, often involving unsafe burial practices. Also, contact tracing efforts are lagging significantly behind the volume of infections. Dr. Jean Kaseya, director general of the Africa CDC, highlighted the gap during a briefing. “If we don’t master this indicator, we’ll not stop this outbreak,” Kaseya said. He added a note of caution regarding control metrics: “I’m not in a position to tell you that we have total control of this outbreak today, because for me to say that, for me to confirm that we achieved the peak and we can start to think about when, maybe, we can stop this outbreak, we need to ensure that all new cases are coming from the contact list. We need to ensure that all deaths are coming from confirmed cases that we have isolated or admitted. This is not the case.”
Angele Gapio, head of emergencies for the Caritas charity in Bunia, pointed out additional operational hurdles. “The disease has now settled in the community,” Gapio told Reuters. “People continue to seek treatment from traditional healers, and the chain of transmission continues.”
Real-Time Clinical Trials Offer Hope Amid Resource Shortages
Medical researchers are conducting parallel trials for vaccines and antiviral therapies directly within the affected regions to alter the course of the epidemic. A vaccine targeting the Bundibugyo strain, developed by the University of Oxford and the Serum Institute of India, reached the clinical trial stage last week. Additionally, a trial evaluating monoclonal antibody MBP134 and remdesivir has enrolled dozens of patients.
Amanda Rojek, associate professor of health emergencies at Oxford’s Pandemic Sciences Institute and operations lead for the trial, explained the strategy in a statement. “One of the key lessons from recent outbreaks is that research needs to happen alongside the response, not after it,” Rojek said. “The PARTNERS trial gives us an opportunity to evaluate potential treatments during the outbreak itself, so that the evidence generated can help inform patient care when it is needed most – in months rather than years.”
Meanwhile, regional neighbors have adjusted their alert levels. Uganda, which previously reported twenty associated cases, declared itself officially Ebola-free this week following enhanced surveillance. Neighboring nations continue to coordinate cross-border containment strategies with Congolese authorities.
Shifting International Response Structures and Oversight
The international community faces structural adjustments in managing foreign aid and diplomatic coordination. The United States government response involves shifting agency roles following the dissolution of USAID and the country’s departure from the WHO last year. While funding and research support remain robust, analysts note potential hurdles in inter-departmental communication and border policy execution. Despite these institutional shifts, the U.S. Centers for Disease Control and Prevention maintains that the risk of domestic spread within the United States remains low due to established public health infrastructure.
Related
Credit: Source link